[Effect of dimethylbiguanide on plasmatic NEFA after carbohydrate administration in obese subjects]. 1968

U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali

UI MeSH Term Description Entries
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
December 1964, Bollettino della Societa italiana di biologia sperimentale,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
January 1967, La Pediatria,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
January 1967, La Clinica terapeutica,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
February 1972, Diabetologia,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
February 1965, Bollettino della Societa italiana di biologia sperimentale,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
January 1968, Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
January 1974, Anales espanoles de pediatria,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
January 1968, Bollettino della Societa italiana di biologia sperimentale,
U Bigozzi, and C Conti, and R Guazzelli, and F Salti, and E Montali
May 1972, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!